What is the treatment for propranolol (beta blocker) overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Propranolol Overdose

High-dose insulin therapy with glucose supplementation is the first-line treatment for propranolol overdose, followed by glucagon administration and vasopressors for patients in refractory shock. 1

Initial Assessment and Stabilization

  • Airway, Breathing, Circulation: Ensure airway protection, provide respiratory support as needed, and establish IV access
  • Monitoring: Continuous cardiac monitoring, blood pressure, blood glucose, potassium, lactate levels, and neurobehavioral status 1
  • Decontamination: If ingestion is recent and airway is protected, consider gastric evacuation to prevent further absorption 2

Treatment Algorithm

First-Line Therapies

  1. High-Dose Insulin Euglycemic Therapy (HIET) 1

    • Initial bolus: 1 U/kg IV
    • Continuous infusion: 1 U/kg/hour
    • Titrate based on clinical response
    • Co-administer with dextrose to maintain euglycemia
    • Monitor blood glucose every 15-30 minutes initially
  2. Glucagon 1, 2

    • Dosing: 50-150 mcg/kg IV bolus (typically 5-10 mg)
    • Follow with continuous infusion of 1-5 mg/hour
    • Caution: May cause vomiting; ensure airway protection
    • Mechanism: Exerts positive inotropic and chronotropic effects
  3. Vasopressors 1, 2

    • Options: Epinephrine, norepinephrine, dopamine
    • Titrate to effect based on blood pressure response
    • Note: Epinephrine may cause uncontrolled hypertension in some cases 2

Second-Line Therapies

  1. Calcium Administration 1

    • Calcium chloride or calcium gluconate IV
    • May repeat every 10-20 minutes for 3-4 doses if beneficial
  2. Atropine 1, 2

    • Dose: 0.5-1 mg IV for symptomatic bradycardia
    • Note: Often has limited efficacy in beta-blocker overdose
  3. Isoproterenol 2

    • May be useful for bradycardia resistant to other treatments
    • Caution with dosing due to potential for hypotension
  4. Intravenous Lipid Emulsion 3

    • Consider in cases unresponsive to conventional therapy
    • Initial dose: 1.5 mL/kg of 20% lipid emulsion over 1 minute
    • Follow with infusion of 0.25 mL/kg/min for 30-60 minutes

Rescue Therapy

  1. Extracorporeal Life Support (VA-ECMO) 1
    • Consider for life-threatening poisoning with cardiogenic shock unresponsive to pharmacological interventions
    • Early consultation with ECMO team recommended

Special Considerations

  • Severe toxicity threshold: ≥2,000 mg in isolated propranolol overdose 4
  • Hemodialysis: Not recommended due to high protein binding and lipophilicity of propranolol 1
  • Bronchospasm: May be treated with isoproterenol and aminophylline 2
  • Hypoglycemia: Monitor closely and treat as needed, especially common with high-dose insulin therapy

Monitoring During Treatment

  • Continuous cardiac monitoring
  • Blood pressure and heart rate
  • Blood glucose levels (every 15-30 minutes initially, then hourly)
  • Serum potassium (risk of hypokalemia with insulin therapy)
  • Neurological status
  • Fluid balance and urine output

Treatment Tapering

  • Begin tapering vasopressors and insulin therapy as the patient stabilizes
  • Continue monitoring for rebound hypotension or bradycardia
  • Observe for at least 24 hours after severe overdose due to risk of delayed toxicity

Pitfalls and Caveats

  • Avoid using epinephrine alone as it may provoke uncontrolled hypertension 2
  • Propranolol toxicity presents with cardiac, neurological, and respiratory manifestations
  • Time interval between ingestion and treatment initiation is critical for prognosis 1
  • Patients with liver disease are at higher risk for beta-blocker toxicity, even at therapeutic doses 1

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.